Nov 12, 2020 4:25pm EST

Cancer Genetics Reports Third Quarter 2020 Financial Results

Nov 02, 2020 4:00pm EST

Cancer Genetics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriter’s Option to Purchase Additional Shares

Oct 28, 2020 9:55pm EDT

Cancer Genetics, Inc. Increases Previously Announced Bought Deal to $3.0 Million

Oct 28, 2020 5:54pm EDT

Cancer Genetics, Inc. Announces $2.0 Million Bought Deal Offering

Sep 10, 2020 8:00am EDT

Cancer Genetics Announces Participation at the 22nd Annual Rodman & Renshaw Global Investment Conference

Sep 03, 2020 8:00am EDT

Cancer Genetics and StemoniX Announce Joint Proof-of-Concept Program

Aug 24, 2020 8:00am EDT

Cancer Genetics and StemoniX Sign Definitive Agreement to Merge

Aug 14, 2020 7:30am EDT

Cancer Genetics Reports Second Quarter 2020 Financial Results

Jun 24, 2020 5:30pm EDT

Cancer Genetics Reports First Quarter 2020 Financial Results and Provides Strategic Business Updates

Jun 01, 2020 8:00am EDT

Cancer Genetics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Strategic Business Updates